Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated September 23, 2020, titled "Sun Pharma Announces the Launch of ILUMYA�� (tildrakizumab) for Treatment of Plaque Psoriasis in Japan".
Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated September 23, 2020, titled "Sun Pharma Announces the Launch of ILUMYA�� (tildrakizumab) for Treatment of Plaque Psoriasis in Japan".